-
1
-
-
84960949820
-
Cancer - A Biological Approach. 3. Viruses Associated with Neoplastic Conditions
-
Burnet, M. Cancer - a Biological Approach. 3. Viruses Associated with Neoplastic Conditions. Brit Med J 1, 841-846 (1957).
-
(1957)
Brit Med J
, vol.1
, pp. 841-846
-
-
Burnet, M.1
-
3
-
-
0035320526
-
A fresh look at tumor immunosurveillance and immunotherapy
-
Smyth, M., Godfrey, D. & Trapani, J. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2, 293-299 (2001).
-
(2001)
Nat Immunol
, vol.2
, pp. 293-299
-
-
Smyth, M.1
Godfrey, D.2
Trapani, J.3
-
4
-
-
84884252997
-
Myeloid-derived suppressor cells in cancer: Recent progress and prospects
-
Khaled, Y., Ammori, B. & Elkord, E. Myeloid-derived suppressor cells in cancer: recent progress and prospects. Immunol Cell Biol 91, 493-502 (2013).
-
(2013)
Immunol Cell Biol
, vol.91
, pp. 493-502
-
-
Khaled, Y.1
Ammori, B.2
Elkord, E.3
-
5
-
-
44349150012
-
Inhibitory B7-family molecules in the tumor microenvironment
-
Zou, W. & Chen, L. Inhibitory B7-family molecules in the tumor microenvironment. Nat Rev Immunol 8, 467-477 (2008).
-
(2008)
Nat Rev Immunol
, vol.8
, pp. 467-477
-
-
Zou, W.1
Chen, L.2
-
6
-
-
40849086381
-
Immunoregulatory T cells: Role and potential as a target in malignancy
-
Beyer, M. & Schultze, J. Immunoregulatory T cells: role and potential as a target in malignancy. Curr Oncol Rep 10, 130-136 (2008).
-
(2008)
Curr Oncol Rep
, vol.10
, pp. 130-136
-
-
Beyer, M.1
Schultze, J.2
-
7
-
-
33751536158
-
Immune selective pressure and HLA class I antigen defects in malignant lesions
-
Chang, C.-C. & Ferrone, S. Immune selective pressure and HLA class I antigen defects in malignant lesions. Cancer Immunol Immun 56, 227-236 (2007).
-
(2007)
Cancer Immunol Immun
, vol.56
, pp. 227-236
-
-
Chang, C.-C.1
Ferrone, S.2
-
8
-
-
0036852191
-
Natural selection of tumor variants in the generation of "tumor escape" phenotypes
-
Khong, H. & Restifo, N. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 3, 999-1005 (2002).
-
(2002)
Nat Immunol
, vol.3
, pp. 999-1005
-
-
Khong, H.1
Restifo, N.2
-
9
-
-
0035865146
-
Role of TGF-beta in immune-evasion of cancer
-
Beck, C., Schreiber, H. & Rowley, D. Role of TGF-beta in immune-evasion of cancer. Microsc Res Techniq 52, 387-395 (2001).
-
(2001)
Microsc Res Techniq
, vol.52
, pp. 387-395
-
-
Beck, C.1
Schreiber, H.2
Rowley, D.3
-
10
-
-
0031932868
-
Immune evasion by tumors: Involvement of the CD95 (APO-1/Fas) system and its clinical implications
-
Strand, S.&Galle, P. Immune evasion by tumors: involvement of the CD95 (APO-1/Fas) system and its clinical implications. Mol Med Today 4, 63-68 (1998).
-
(1998)
Mol Med Today
, vol.4
, pp. 63-68
-
-
Strand, S.1
Galle, P.2
-
11
-
-
0036852241
-
Cancer immunoediting: From immunosurveillance to tumor escape
-
Dunn, G., Bruce, A., Ikeda, H., Old, L. & Schreiber, R. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3, 991-998 (2002).
-
(2002)
Nat Immunol
, vol.3
, pp. 991-998
-
-
Dunn, G.1
Bruce, A.2
Ikeda, H.3
Old, L.4
Schreiber, R.5
-
12
-
-
0026503190
-
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor
-
Aslakson, C. & Miller, F. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52, 1399-1405 (1992).
-
(1992)
Cancer Res
, vol.52
, pp. 1399-1405
-
-
Aslakson, C.1
Miller, F.2
-
13
-
-
0023633109
-
Analysis of tumor cell composition in tumors composed of paired mixtures of mammary tumor cell lines
-
Miller, B., Miller, F., Wilburn, D. & Heppner, G. Analysis of tumor cell composition in tumors composed of paired mixtures of mammary tumor cell lines. Brit J Cancer 56, 561-569 (1987).
-
(1987)
Brit J Cancer
, vol.56
, pp. 561-569
-
-
Miller, B.1
Miller, F.2
Wilburn, D.3
Heppner, G.4
-
14
-
-
33845944941
-
Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: Association with tumor-derived growth factors
-
DuPre, S. & Hunter, K. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp Mol Pathol 82, 12-24 (2007).
-
(2007)
Exp Mol Pathol
, vol.82
, pp. 12-24
-
-
DuPre, S.1
Hunter, K.2
-
15
-
-
67349133537
-
Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
-
Le, H. et al. Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Int immunopharmacol 9, 900-909 (2009).
-
(2009)
Int Immunopharmacol
, vol.9
, pp. 900-909
-
-
Le, H.1
-
16
-
-
61349100687
-
Myeloid-derived suppressor cells as regulators of the immune system
-
Gabrilovich,D. &Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9, 162-174 (2009).
-
(2009)
Nat Rev Immunol
, vol.9
, pp. 162-174
-
-
Gabrilovich, D.1
Nagaraj, S.2
-
17
-
-
35448954376
-
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression
-
Bunt, S. K. et al. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res 67, 10019-10026 (2007).
-
(2007)
Cancer Res
, vol.67
, pp. 10019-10026
-
-
Bunt, S.K.1
-
18
-
-
4143141823
-
The immunobiology of cancer immunosurveillance and immunoediting
-
Dunn, G., Old, L. & Schreiber, R. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137-148 (2004).
-
(2004)
Immunity
, vol.21
, pp. 137-148
-
-
Dunn, G.1
Old, L.2
Schreiber, R.3
-
19
-
-
0027411525
-
TheMolecular Cell Biology of Interferon-gamma and its Receptor
-
Farrar, M. A. & Schreiber, R. D. TheMolecular Cell Biology of Interferon-gamma and its Receptor. Annual Review of Immunol 11, 571-611 (1993).
-
(1993)
Annual Review of Immunol
, vol.11
, pp. 571-611
-
-
Farrar, M.A.1
Schreiber, R.D.2
-
20
-
-
0036681991
-
Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma
-
Pulaski, B., Smyth, M. & Ostrand-Rosenberg, S. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma. Cancer Res 62, 4406-4412 (2002).
-
(2002)
Cancer Res
, vol.62
, pp. 4406-4412
-
-
Pulaski, B.1
Smyth, M.2
Ostrand-Rosenberg, S.3
-
21
-
-
1642279609
-
Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms
-
Shi, X., Cao, S., Mitsuhashi, M., Xiang, Z. & Ma, X. Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms. J Immunol 172, 4111-4122 (2004).
-
(2004)
J Immunol
, vol.172
, pp. 4111-4122
-
-
Shi, X.1
Cao, S.2
Mitsuhashi, M.3
Xiang, Z.4
Ma, X.5
-
22
-
-
55149111143
-
Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation
-
Maynard, C. & Weaver, C. Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol Rev 226, 219-233 (2008).
-
(2008)
Immunol Rev
, vol.226
, pp. 219-233
-
-
Maynard, C.1
Weaver, C.2
-
23
-
-
0032868805
-
Effects of TGF-beta on the immune system: Implications for cancer immunotherapy
-
de Visser, K. & Kast, W. Effects of TGF-beta on the immune system: implications for cancer immunotherapy. Leukemia 13, 1188-1199 (1999).
-
(1999)
Leukemia
, vol.13
, pp. 1188-1199
-
-
De Visser, K.1
Kast, W.2
-
24
-
-
45549088943
-
Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17
-
Nam, J.-S. et al. Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res 68, 3915-3923 (2008).
-
(2008)
Cancer Res
, vol.68
, pp. 3915-3923
-
-
Nam, J.-S.1
-
25
-
-
56649118964
-
TGF-beta and regulatory T cell in immunity and autoimmunity
-
Wan, Y. & Flavell, R. TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol 28, 647-659 (2008).
-
(2008)
J Clin Immunol
, vol.28
, pp. 647-659
-
-
Wan, Y.1
Flavell, R.2
-
26
-
-
0021690467
-
Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F
-
Pircher, R., Lawrence, D. & Jullien, P. Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F. Cancer Res 44, 5538-5543 (1984).
-
(1984)
Cancer Res
, vol.44
, pp. 5538-5543
-
-
Pircher, R.1
Lawrence, D.2
Jullien, P.3
-
27
-
-
36148994693
-
The other side of MMPs: Protective roles in tumor progression
-
Martin, M. & Matrisian, L. The other side of MMPs: protective roles in tumor progression. Cancer Metast Rev 26, 717-724 (2007).
-
(2007)
Cancer Metast Rev
, vol.26
, pp. 717-724
-
-
Martin, M.1
Matrisian, L.2
-
28
-
-
0032323358
-
Prognostic significance of soluble Fas in the serum of patients with bladder cancer
-
Mizutani, Y., Yoshida, O. & Bonavida, B. Prognostic significance of soluble Fas in the serum of patients with bladder cancer. J Urol 160, 571-576 (1998).
-
(1998)
J Urol
, vol.160
, pp. 571-576
-
-
Mizutani, Y.1
Yoshida, O.2
Bonavida, B.3
-
29
-
-
0032737486
-
Circulating soluble Fas concentration in breast cancer patients
-
Ueno, T., Toi, M. & Tominaga, T. Circulating soluble Fas concentration in breast cancer patients. Clin Cancer Res 5, 3529-3533 (1999).
-
(1999)
Clin Cancer Res
, vol.5
, pp. 3529-3533
-
-
Ueno, T.1
Toi, M.2
Tominaga, T.3
-
30
-
-
0033064690
-
Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
-
Kimura, M. et al. Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients. Br J Cancer 80, 1648-1651 (1999).
-
(1999)
Br J Cancer
, vol.80
, pp. 1648-1651
-
-
Kimura, M.1
-
31
-
-
0031783087
-
Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma
-
Jodo, S. et al. Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma. Clin Exp Immunol 112, 166-171 (1998).
-
(1998)
Clin Exp Immunol
, vol.112
, pp. 166-171
-
-
Jodo, S.1
-
32
-
-
0033822691
-
Serum soluble Fas level as a prognostic factor in patients with gynecological malignancies
-
Konno, R., Takano, T., Sato, S.&Yajima, A. Serum soluble Fas level as a prognostic factor in patients with gynecological malignancies. Clin Cancer Res 6, 3576-3580 (2000).
-
(2000)
Clin Cancer Res
, vol.6
, pp. 3576-3580
-
-
Konno, R.1
Takano, T.2
Sato, S.3
Yajima, A.4
-
33
-
-
0034034661
-
Serum soluble Fas levels in ovarian cancer
-
Hefler, L. et al. Serum soluble Fas levels in ovarian cancer. Obstet Gynecol 96, 65-69 (2000).
-
(2000)
Obstet Gynecol
, vol.96
, pp. 65-69
-
-
Hefler, L.1
-
34
-
-
0035571794
-
Serum soluble Fas level for detection and staging of prostate cancer
-
Furuya, Y., Fuse, H. &Masai, M. Serum soluble Fas level for detection and staging of prostate cancer. Anticancer Res 21, 3595-3598 (2001).
-
(2001)
Anticancer Res
, vol.21
, pp. 3595-3598
-
-
Furuya, Y.1
Fuse, H.2
Masai, M.3
-
35
-
-
0032400862
-
Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
-
Gabrilovich, D. et al. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92, 4150-4166 (1998).
-
(1998)
Blood
, vol.92
, pp. 4150-4166
-
-
Gabrilovich, D.1
-
36
-
-
50549218525
-
The Limited in Vitro Lifetime ofHuman Diploid Cell Strains
-
Hayflick, L. The Limited in Vitro Lifetime ofHuman Diploid Cell Strains. Exp Cell Res 37, 614-636 (1965).
-
(1965)
Exp Cell Res
, vol.37
, pp. 614-636
-
-
Hayflick, L.1
-
37
-
-
78349257844
-
The essence of senescence
-
Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Gene Dev 24, 2463-2479 (2010).
-
(2010)
Gene Dev
, vol.24
, pp. 2463-2479
-
-
Kuilman, T.1
Michaloglou, C.2
Mooi, W.J.3
Peeper, D.S.4
-
38
-
-
81855169964
-
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
-
Kang, T. W. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547-551 (2011).
-
(2011)
Nature
, vol.479
, pp. 547-551
-
-
Kang, T.W.1
-
39
-
-
84874192617
-
T-helper-1-cell cytokines drive cancer into senescence
-
Braumuller, H. et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 494, 361-365 (2013).
-
(2013)
Nature
, vol.494
, pp. 361-365
-
-
Braumuller, H.1
-
40
-
-
58849154235
-
Senescence-messaging secretome: SMS-ing cellular stress
-
Kuilman, T. & Peeper, D. S. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 9, 81-94 (2009).
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 81-94
-
-
Kuilman, T.1
Peeper, D.S.2
-
41
-
-
10744231991
-
Endothelial cells require STAT3 for protection against endotoxin-induced inflammation
-
Kano, A. et al. Endothelial cells require STAT3 for protection against endotoxin-induced inflammation. J Exp Med 198, 1517-1525 (2003).
-
(2003)
J Exp Med
, vol.198
, pp. 1517-1525
-
-
Kano, A.1
|